Poster

P1

A novel LC/MS lipidomics workflow for biomarker profiling and biochemical studies

A. Othman1, T. Hornemann1, A. von Eckardstein1 (1Schlieren)

View abstract


P2

Protective Function of Macrophage Nuclear Receptor Corepressor 1 in Atherosclerosis

S. Oppi1, S. Nusser-Stein1, P. Blyszczuk2, S. Marzolla1, E. Osto3, A. Othman2, T. Hornemann2, K. Schoonjans4, J. Auwerx4, M. Oosterveer5, T. Lüscher1, S. Stein1 (1Schlieren; 2Zurich; 3Schwerzenbach; 4Lausanne; 5Groningen)

View abstract


P3

Anti-apolipoprotein A-1 autoantibodies prevalence is increased with HIV infection

M. Frias1, S. Pagano1, V. Fétaud-Lapierre1, S. Lecour2, F. Kamau3, H. Strijdom3, N. Vuilleumier1 (1Geneva; 2Cap Town; 3Stellenbosch)

View abstract


P4

Lipoprotein apheresis for the pregnancy of a patient with compound heterozygote familial hypercholesterolemia and elevated lipoprotein(a) levels – How and when should we switch treatment in the era of PCSK9 monoclonal antibodies?

T. H. Collet1, F. Beaud1, C. Kosinski1, A. Panchaud Monnat1, D. Baud1, S. Kissling1 (1Lausanne)

View abstract


P5

Clinical and Genetic Features of Familial Hypercholesterolemia in Eastern Switzerland

S. Bilz1, A. Ebert1, Y. Gerth1, K. Jung1, W. Korte1 (1St. Gallen)

View abstract


P6

Betatrophin Predicts Cardiovascular Events Independently from the Presence of Type 2 Diabetes and Coronary Artery Disease

A. Leiherer1, A. Muendlein1, K. Geiger1, C. Saely2, E. M. Brandtner1, J. Ebner1, B. Larcher1, A. Mader1, P. Fraunberger1, H. Drexel3 (1Feldkirch; 2Triesen; 3Bern)

View abstract


P7

Adherence to Lipid lowering therapy drives the outcome of patients with symptomatic peripheral artery disease 

J. Dopheide1, J. Veit1, H. Ramadani1, L. Adam1, L. Papac1, M. Schindewolf1, A. Vonbank2, I. Baumgartner1, H. Drexel1 (1Bern; 2Feldkirch)

View abstract


P8

Control of cardiovascular risk factors in patients not reaching Swiss health insurance reimbursement criteria for protein convertase subtilisin/kexin-9 inhibitors one year after an acute coronary syndrome

A. Butty1, B. Gencer2, K. Koskinas3, D. Carballo2, L. Räber3, R. Klingenberg4, C. Matter4, T. Lüscher5, S. Windecker3, F. Mach2, N. Rodondi3, O. Muller1, D. Nanchen1 (1Lausanne; 2Geneva; 3Bern; 4Zurich; 5London)

View abstract


P9

The Novel Adipokine C1QTNF1 Significantly Predicts the Incidence of Future Major Cardiovascular Events in Patients with Type 2 Diabetes

A. Muendlein1, A. Leiherer1, C. Saely2, K. Geiger1, J. Ebner1, E. M. Brandtner1, B. Larcher1, A. Mader1, P. Fraunberger1, H. Drexel3 (1Feldkirch; 2Triesen; 3Bern)

View abstract


P10

Single and Combined Effects of Peripheral Artery Disease and of Type 2 Diabetes Mellitus on the Risk of Cardiovascular Events in Women

C. Saely1, M. Schindewolf2, A. Vonbank3, C. Heinzle3, D. Purin3, B. Larcher3, A. Mader3, A. Leiherer3, A. Muendlein3, H. Drexel2, I. Baumgartner2 (1Triesen; 2Bern; 3Feldkirch)

View abstract


P11

Patient and caregiver productivity loss and indirect costs in the first year following cardiovascular events in Switzerland

E. Carrera1, F. Mach1, K. Koskinas2, P. Lyrer3, R. Hullin4, C. Wanger5, E. Sidelnikov5 (1Geneva; 2Bern; 3Basel; 4Lausanne; 5Rotkreuz)

View abstract


P12

Development of a three-dimensional prognostic score for patients with symptomatic peripheral arterial disease (PAD3D Score) – a piece of personalized medicine

H. Ramadani1, J. Dopheide1, L. Adam1, L. Papac1, J. Veit1, M. Schindewolf1, I. Baumgartner1, H. Drexel1 (1Bern)

View abstract


P13

Gestational Diabetes Mellitus as a Potential Risk Factor for Metabolic Syndrome in the Early and Late Postpartum Period – A prospective cohort study

C. Kosinski1, T. H. Collet1, J. Gross1, C. Helbling1, D. Y. Quansah1, J. J. Puder1 (1Lausanne)

View abstract


P14

Targeted Metabolomics Identifies Elevated Serotonin Levels in Carriers of a TCF7L2 Diabetes-Risk Allele

A. Leiherer1, A. Muendlein1, K. Geiger1, C. Saely2, E. M. Brandtner1, J. Ebner1, B. Larcher1, A. Mader1, P. Fraunberger1, H. Drexel3 (1Feldkirch; 2Triesen; 3Bern)

View abstract


P15

The A Body Shape Index and Type 2 Diabetes are Mutually Independent Predictors of Cardiovascular Events in Patients with Peripheral Artery Disease

A. Vonbank1, C. Saely2, C. Heinzle1, D. Purin1, B. Larcher1, A. Mader1, A. Leiherer1, A. Muendlein1, H. Drexel3 (1Feldkirch; 2Triesen; 3Bern)

View abstract


P16

Elevated Parathyroid Hormone is Associated With an Increased Mortality Risk in Type 2 Diabetes

A. Muendlein1, A. Leiherer1, C. Saely2, K. Geiger1, E. M. Brandtner1, B. Larcher1, A. Mader1, P. Fraunberger1, M. Kleber3, A. Dressel4, W. März3, H. Drexel5 (1Feldkirch; 2Triesen; 3Mannheim; 4Hamburg; 5Bern)

View abstract


P17

Scavenger receptor SR-BI splice variants 1 and 2 differ by cellular localization and interaction with HDL in endothelial cells

A. Potapenko (Schlieren)

View abstract


P18

The Visceral Adiposity Index is a Significantly Stronger Predictor of Incident Diabetes in Men than in Women

C. Saely1, A. Vonbank2, C. Heinzle2, D. Purin2, B. Larcher2, A. Mader2, A. Leiherer2, A. Muendlein2, H. Drexel3 (1Triesen; 2Feldkirch; 3Bern)

View abstract


P19

Advanced carotid atherosclerosis in middle-aged subjects: comparison to PROCAM and SCORE risk categories, the potential for reclassification and cost-efficiency of carotid ultrasound in the setting of primary care.

M. Romanens1, I. Sudano2, A. Adams3 (1Olten; 2Zurich; 3Koblenz)

View abstract